Peter Pereira

Peter Pereira has a strategic focus with brilliant technical ability; he is great to work with and somebody you want to have on your team. - Chambers UK, 2026

Peter Pereira is a partner in the Intellectual Property Litigation Team in Kirkland’s London office. He has a broad practice across all aspects of IP litigation with particular experience coordinating global patent litigation for high tech companies.

Peter has extensive experience in SEP/FRAND litigation acting for both implementers and SEP holders. He has been a pioneer in establishing the “FRAND-first” jurisdiction of the UK High Court. Peter was counsel for Thales who successfully sought the first-ever FRAND-first trial in the UK without an antecedent technical trial.

Peter also has substantial experience across technical fields including cellular, wireless, connectivity and audio/video codec (standardised and non-standardised) technologies. He has conducted – and won – multiple technical trials in the UK, most recently on behalf of Samsung against ZTE in a judgment of the High Court on August 28, 2026.

Peter is currently counsel for Paramount against Nokia in its expedited RAND rate-setting trial being heard in November/December 2026. He was counsel for Hisense in its rate-setting action against Nokia which ultimately settled shortly after Hisense had obtained an interim licence against Nokia.

The Legal 500 UK has described Peter as having “expertise in SEP and FRAND litigation for international telecoms and technology clients”. Peter has “high expertise, excellent work commitment, dedication to case, [and is] prepared to consider novel approaches to achieve practical goals”. The 2026 edition notes that Peter “is a hardworking and gifted lawyer who deserves every accolade”. Chambers UK 2026 says, “Peter Pereira has a strategic focus with brilliant technical ability; he is great to work with and somebody you want to have on your team.” JUVE Patent describes Peter as “a rising star - he is young but very good”. Peter is also recognised as a Notable Practitioner in Managing IP’s IP Stars.

In 2020, Peter was the joint winner of the AIPPI UK study prize for his submission on the topic of descriptive use as a defense in trade mark proceedings.

In 2019–2020, Peter was seconded from Kirkland to GSK’s Consumer Healthcare business, where his work included supporting GSK’s £10 billion joint venture with Pfizer on their respective consumer health businesses, negotiating licenses and handling all litigious trade mark matters.